After immunotherapy for advanced colon cancer, the tumor shrank, and the recurrence and metastasis stopped... The patient has survived for over 12 years

In late 2015, by a twist of fate, Mr. Zhang met Professor Zhang Minghui, a professor of immunology at Tsinghua University. After communication, Mr. Zhang regained hope for his life. After a comprehensive understanding of Mr. Zhang's condition, the Lehexin Medical team provided a second diagnosis and treatment suggestion based on a comprehensive evaluation:

1. After the first surgery, the pathology report indicated moderately differentiated adenocarcinoma, with visible tumor thrombus in the vessels and lymph node metastasis, suggesting a high risk of postoperative recurrence.

2. Mr. Zhang had recurrent colon cancer after surgery, and although he underwent a second surgery, multiple enlarged lymph nodes in the hepatic hilum and retroperitoneum still persisted, which is a potential risk for future recurrence and metastasis.

3. Multiple surgeries and chemotherapy had damaged Mr. Zhang's body and immune system. Timely intervention with vNKT cell therapy at this time can eliminate residual cancer cells in the body and activate the body's immune system to fight against tumors. vNKT cell therapy is mild and has no side effects, making it very suitable for Mr. Zhang's weak and physically exhausted state.

4. It is recommended that Mr. Zhang take both oral chemotherapy drugs and vNKT cell therapy, and after controlling the recurrence and metastasis, continue to use vNKT cell therapy to eliminate residual cancer cells.

In July 2015, Mr. Zhang underwent vNKT cell therapy. During the first year of treatment (August 2015 to August 2016, with 12 courses of NKT infusion), the retroperitoneal lymph nodes still showed a trend of gradual fusion and enlargement, increasing from 1.2*0.9cm (August 2015) to 2.9*2.0cm (August 2016). Precision radiotherapy was adopted for intervention, followed by continued maintenance with the vNKT cell therapy regimen. On August 9, 2017, the lesion shrank to 0.4*0.8cm and remained stable during multiple follow-up examinations. We can see that under the suppression of vNKT cells, the tumor, which had previously undergone frequent metastasis, was gradually inhibited, achieving Mr. Zhang's goal of living with the tumor. By 2022, the lymph nodes had shrunk again, and by 2023, they had completely disappeared during follow-up examinations, finally putting Mr. Zhang and his family's minds at ease.

Nearly 12 years have passed since Mr. Zhang was diagnosed with cancer, far surpassing the initial "prophecy" of the doctor regarding his survival period. Therefore, recurrent recurrence and metastasis during the treatment of cancer patients is a very common phenomenon. One should not be afraid or panic. When new lesions appear, precision radiotherapy can be used to treat them, combined with vNKT cell immunotherapy for "stability maintenance," which can also achieve the goal of prolonging survival and improving quality of life. As of July 2023, 89 courses of treatment have been completed, and treatment is still being carried out as planned.

Being diagnosed with cancer is unfortunate, but fortunately, during his illness, Mr. Zhang received meticulous care from his family, who encouraged him to express his inner fears and worries while being patiently listened to and accompanied, demonstrating unwavering confidence and positive emotions, making him feel hopeful and firmly believing that he could overcome cancer.

After diagnosis, as the condition gradually worsened, to alleviate Mr. Zhang's inner fear and worry, his family chose to conceal part of his condition. It was not until later when Mr. Zhang learned the truth that he was very grateful for his family's approach. The diagnosis was at an advanced stage, and if he had known about multiple metastases, he might not have been able to face the subsequent treatment. Therefore, as a patient's family, it is appropriate to conceal part of the condition according to the actual situation, ensuring the smooth progress of treatment while also building the patient's confidence in fighting cancer.

Mr. Zhang shifted his mindset, viewing this battle against cancer, which is not a war with gunsmoke, as a spiritual journey in life, perhaps a test of his proud nature by the heavens. He realized a truth: we need to maintain an optimistic mindset and broad-mindedness at all times, as only in this way can we achieve health and happiness.

After undergoing vNKT treatment, Mr. Zhang has not experienced recurrence or metastasis for 9 years. Now, Mr. Zhang has shed the heavy burden of having a tumor, enjoys spending time with his grandchildren, and even often helps his wife with household chores, greatly improving his quality of life.

Mr. Zhang's 12-year battle with cancer is a medical miracle created by science, technology, and psychological support. Despite experiencing tumor recurrence and undergoing another surgery, vNKT cell therapy stabilized his condition given the high malignancy of the tumor. This shows that vNKT cell immunotherapy plays an indispensable role in reducing the risk of recurrence and metastasis. Meanwhile, while actively cooperating with treatment, Mr. Zhang promptly adjusted his mindset, established a strong belief in fighting cancer, and never gave up, which also played an important role in providing positive psychological support!

Mr. Zhang hopes to tell everyone through his own experience that tumors are not terrible, and miracles can happen at any time.